Registration fees: Academic Attendee: $195, General Attendee: $395
Register here: Click here to register for this event
Register for this ground-breaking inaugural event to explore new solutions, promising technology breakthroughs and how industry can introduce and incorporate improved approaches in drug development.
The program, proudly sponsored by Juniper Pharma Services, includes an opening keynote: ‘Minimizing CMC Risk to Maximize Probability of Success’ from Anthony A. McKinney, Founder, President & CEO, Ethismos, Founder and Chief Development Officer, Neurovance, Inc.
This is followed by focused discussions with our panel of specialists from Tesaro, Shire Pharmaceuticals, TetraScience and Covaris amongst others, demonstrating some of the approaches to address complex formulation development and manufacturing challenges in the area of small molecule compounds.
Other guest speakers include:
- Manuel Sanchez-Felix, Ph.D., Senior Fellow, Novel Delivery Technologies, Novartis Institute for Biomedical Research.
- Padma Narayan, Ph.D., Director, Formulation Development, Tech Ops Development, SAGE Therapeutics.
The closing keynote comes from Ibis Sánchez-Serrano, MBA, President & CEO of “The Core Model Corporation” (C.M.C.) and Calestous Juma, Professor of the Practice of International Development, and Director of the Science, Technology, and Globalization Project at the Belfer Center for Science and International Affairs of the Harvard Kennedy School who will discuss: ‘Breaking Down Barriers to Adoption of New Technology’.
The forum will also explore how consultants, CROs and CMOs must invest in their resources to meet the evolving demands of drug development. The event is designed to bring a focused group together to exchange ideas and experiences and conduct a very deep and important dive into the real-world challenges of biotech and pharma drug development.
About Juniper Pharma Services
Juniper Pharma Services is a contract development and manufacturing organization (CDMO) specializing in science-led solutions for pharmaceutical development. The business provides expertise, R&D infrastructure and manufacturing capabilities to transform clients’ promising molecules into successful products for unmet medical needs. Researching, developing and manufacturing new formulations for ground-breaking medicines is at the core of its services.
For more information, visit www.juniperpharma.com, follow on Twitter @JuniperServices or Linkedin https://www.linkedin.com/company/juniper-pharma-services